Hefei Enruite Pharmaceutical

Hefei Enruite Pharmaceutical is a specialized pharmaceutical enterprise located in Hefei, China, primarily focused on the development and production of high-barrier generic drugs and innovative small molecule therapeutics. As a key subsidiary of the publicly traded Hefei Cube Pharmaceutical, the company maintains a strong presence in the cardiovascular, metabolic, and inflammatory disease markets. Their product portfolio is highlighted by complex formulations such as Sacubitril Valsartan Sodium tablets and a range of anticoagulants and anti-diabetic agents. The company leverages integrated R&D and manufacturing capabilities, operating state-of-the-art GMP facilities to ensure high-quality production from active pharmaceutical ingredients (APIs) to finished dosage forms. Enruite is recognized for its technical expertise in drug delivery systems and its commitment to providing high-quality medicine within the Chinese domestic market.